| scholarly article | Q13442814 |
| P50 | author | Felicia Goodrum | Q57649749 |
| P2093 | author name string | Michael A Thomas | |
| David A Ornelles | |||
| Robin S Broughton | |||
| P2860 | cites work | Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions | Q22010220 |
| Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 | ||
| Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53 | Q24323169 | ||
| Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins | Q24527216 | ||
| Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2 | Q24533404 | ||
| Link of the unique oncogenic properties of adenovirus type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2 | Q24535830 | ||
| Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery | Q24538586 | ||
| Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins | Q24622878 | ||
| Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1 | Q24635316 | ||
| Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton | Q24685127 | ||
| Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product | Q28114879 | ||
| PDZ domains and the organization of supramolecular complexes | Q28209906 | ||
| Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB | Q28306356 | ||
| Specificity and mechanism of action of some commonly used protein kinase inhibitors | Q28344791 | ||
| p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD | Q28592766 | ||
| Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex | Q29041391 | ||
| Cellular survival: a play in three Akts | Q29547806 | ||
| Rational design and characterization of a Rac GTPase-specific small molecule inhibitor | Q29616494 | ||
| Phosphoinositide kinases | Q29618047 | ||
| Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication | Q33649728 | ||
| Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication | Q33780662 | ||
| p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection | Q33785919 | ||
| Regulation of p70 S6 kinase by complex formation between the Rac guanine nucleotide exchange factor (Rac-GEF) Tiam1 and the scaffold spinophilin | Q34171088 | ||
| Quantitation of G0 and G1 phase cells in primary carcinomas. Antibody to M1 subunit of ribonucleotide reductase shows G1 phase restriction point block | Q34236717 | ||
| Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells | Q34340236 | ||
| An adenovirus mutant that replicates selectively in p53-deficient human tumor cells | Q34399844 | ||
| Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus | Q34469114 | ||
| Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection | Q34562704 | ||
| Regulation of mRNA production by the adenoviral E1B 55-kDa and E4 Orf6 proteins | Q35127696 | ||
| E4orf3 is necessary for enhanced S-phase replication of cell cycle-restricted subgroup C adenoviruses | Q35155212 | ||
| Regulation of Tiam1-Rac signalling. | Q35163913 | ||
| Replicative oncolytic adenoviruses in multimodal cancer regimens | Q35180181 | ||
| Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export | Q35634994 | ||
| The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle | Q35875344 | ||
| Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. | Q35883364 | ||
| Inactivating intracellular antiviral responses during adenovirus infection | Q36318156 | ||
| Functionally distinct monomers and trimers produced by a viral oncoprotein | Q36318620 | ||
| Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein | Q36410968 | ||
| Control of mRNA export by adenovirus E4orf6 and E1B55K proteins during productive infection requires E4orf6 ubiquitin ligase activity | Q36484050 | ||
| E4Orf6-E1B-55k-dependent degradation of de novo-generated adeno-associated virus type 5 Rep52 and capsid proteins employs a cullin 5-containing E3 ligase complex | Q36498213 | ||
| Adenovirus type 9 E4 open reading frame 1 encodes a transforming protein required for the production of mammary tumors in rats | Q36634353 | ||
| APOBEC-mediated viral restriction: not simply editing? | Q36736677 | ||
| Clinical trials with oncolytic adenovirus in China | Q36754441 | ||
| Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff | Q36851240 | ||
| The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs | Q36909556 | ||
| Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis. | Q36914451 | ||
| The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway | Q37003173 | ||
| Advances in the structural understanding of Vif proteins | Q37108363 | ||
| Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy | Q37108598 | ||
| Oncogenic potential of the adenovirus E4orf6 protein | Q37247046 | ||
| Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background | Q37492831 | ||
| Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis | Q38303570 | ||
| Distinct requirements of adenovirus E1b55K protein for degradation of cellular substrates | Q39963290 | ||
| Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein | Q39982335 | ||
| Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation | Q40140948 | ||
| Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes | Q40384561 | ||
| Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages | Q40400107 | ||
| E3 transcription unit of adenovirus | Q40411741 | ||
| Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins | Q40423325 | ||
| Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication | Q40445488 | ||
| Adenovirus E4-34kDa requires active proteasomes to promote late gene expression | Q40621055 | ||
| Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex | Q40717443 | ||
| Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis | Q41563751 | ||
| Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells | Q41975913 | ||
| Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response | Q42040593 | ||
| Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice | Q42197810 | ||
| Adenovirus early region 4 and viral DNA synthesis | Q42620900 | ||
| The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. | Q42812980 | ||
| Rac1 prevents cisplatin-induced apoptosis through down-regulation of p38 activation in NIH3T3 cells. | Q42815640 | ||
| The ras-related GTPase rac1 regulates a proliferative pathway selectively utilized by G-protein coupled receptors | Q42825044 | ||
| Rac1 inhibits TNF-alpha-induced endothelial cell apoptosis: dual regulation by reactive oxygen species | Q43506772 | ||
| Interaction of adenoviral E4 and E1b products in late gene expression | Q44444174 | ||
| Modified method of mammalian cell synchronization improves yield and degree of synchronization | Q44953098 | ||
| China approves world's first oncolytic virus therapy for cancer treatment | Q45419325 | ||
| Adenovirus overrides cellular checkpoints for protein translation | Q46132694 | ||
| Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins | Q48082495 | ||
| Analysis of adenovirus infections in synchronized cells. | Q50950146 | ||
| Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53 | Q64377210 | ||
| Isolation of deletion and substitution mutants of adenovirus type 5 | Q64382239 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| oncolytic virus | Q1560099 | ||
| P304 | page(s) | 2406-2416 | |
| P577 | publication date | 2009-01-07 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus | |
| P478 | volume | 83 |
| Q39707314 | Adenovirus late-phase infection is controlled by a novel L4 promoter. |
| Q35488742 | Adenovirus replaces mitotic checkpoint controls |
| Q36071414 | Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector. |
| Q35021632 | Effects of the deletion of early region 4 (E4) open reading frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on virus-host cell interaction, transgene expression, and immunogenicity of replicating adenovirus HIV vaccine vectors |
| Q39429511 | Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer |
| Q35734826 | Intracellular transport of recombinant adeno-associated virus vectors |
| Q37416907 | Intrinsic cellular signaling mechanisms determine the sensitivity of cancer cells to virus-induced apoptosis. |
| Q33906116 | Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles |
| Q41699675 | Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer |
| Q91776793 | Optimizing oncolytic virotherapy in cancer treatment |
| Q38201237 | Rho'ing in and out of cells: viral interactions with Rho GTPase signaling |
| Q64376883 | Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX |
| Q41919532 | Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses |
| Q33931595 | Targeting of p53-transcriptional dysfunction by conditionally replicating adenovirus is not limited by p53-homologues |
| Q38064834 | Tinkering with translation: protein synthesis in virus-infected cells |
Search more.